CRISPR/Cas9 system and its applications in nervous system diseases

Haibin Jiang; Mengyan Tang; Zidi Xu; Yanan Wang; Mopu Li; Shuyin Zheng; Jianghu Zhu; Zhenlang Lin; Min Zhang

doi:10.1016/j.gendis.2023.03.017

您当前的位置：

首页 >

文章列表页 >

CRISPR/Cas9 system and its applications in nervous system diseases

Review article | 更新时间：2024-02-04

- CRISPR/Cas9 system and its applications in nervous system diseases
- CRISPR/Cas9 system and its applications in nervous system diseases
- Genes & Diseases 2024年11卷第2期
- 作者机构：
  
  1. Key Laboratory of Perinatal Medicine of Wenzhou,Zhejiang,Wenzhou,China,325027
  2. The Second School of Medicine, Wenzhou Medical University,Zhejiang,Wenzhou,China,325035
  3. Key Laboratory of Structural Malformations in Children of Zhejiang Province,Zhejiang,Wenzhou,China,325000
  4. Department of Pediatrics, The Second School of Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,China,325027
  5. Zhejiang Provincial Clinical Research Center for Pediatric Disease,Zhejiang,Wenzhou,China,325027
  6. The First School of Medicine, Wenzhou Medical University,Zhejiang,Wenzhou,China,325035
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.03.017
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-3-1，
扫描看全文
Haibin Jiang, Mengyan Tang, Zidi Xu, 等. CRISPR/Cas9 system and its applications in nervous system diseases[J]. Genes & Diseases, 2024,11(2).

Haibin Jiang, Mengyan Tang, Zidi Xu, et al. CRISPR/Cas9 system and its applications in nervous system diseases[J]. Genes & Diseases, 2024,11(2).
Haibin Jiang, Mengyan Tang, Zidi Xu, 等. CRISPR/Cas9 system and its applications in nervous system diseases[J]. Genes & Diseases, 2024,11(2). DOI： 10.1016/j.gendis.2023.03.017.

Haibin Jiang, Mengyan Tang, Zidi Xu, et al. CRISPR/Cas9 system and its applications in nervous system diseases[J]. Genes & Diseases, 2024,11(2). DOI： 10.1016/j.gendis.2023.03.017.

摘要

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system is an acquired immune system of many bacteria and archaea

comprising

CRISPR

loci

Cas

genes

and its associated proteins. This system can recognize exogenous DNA and utilize the Cas9 protein's nuclease activity to break DNA double-strand and to achieve base insertion or deletion by subsequent DNA repair. In recent years

multiple laboratory and clinical studies have revealed the therapeutic role of the CRISPR/Cas9 system in neurological diseases. This article reviews the CRISPR/Cas9-mediated gene editing technology and its potential for clinical application against neurological diseases.

关键词

Keywords

CRISPR/Cas9Gene editingMutationNeurological diseasesTherapeutics

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Nucleolus localization of SpyCas9 affects its stability and interferes with host protein translation in mammalian cells

RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities

Mitochondrial diseases and mtDNA editing

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine

Emerging chemical engineering of exosomes as “bioscaffolds” in diagnostics and therapeutics